Abstract:The ever-growing drug resistance problem worldwide highlights the urgency to discover and develop new drugs. Microbial natural products are a prolific source of drugs. Genome sequencing has revealed a tremendous amount of uncharacterized natural product biosynthetic gene clusters (BGCs) encoded within microbial genomes, most of which are cryptic or express at very low levels under standard culture conditions. Therefore, developing effective strategies to awaken these cryptic BGCs is of great interest for natural product discovery. In this study, we designed and validated a Transcription–Translation in One (TTO) approach for activation of cryptic BGCs. This approach aims to alter the metabolite profiles of target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding RNA polymerase β subunit) genes containing beneficial mutations for natural product production using a plug-and-play plasmid system. As a result, this approach bypasses the tedious screening work and overcomes the false positive problem in the traditional ribosome engineering approach. In this work, the TTO approach was successfully applied to activating cryptic BGCs in three Streptomyces strains, leading to the discovery of two aromatic polyketide antibiotics, piloquinone and homopiloquinone. We further identified a single BGC responsible for the biosynthesis of both piloquinone and homopiloquinone, which features an unusual starter unit incorporation step. This powerful strategy can be further exploited for BGC activation in strains even beyond streptomycetes, thus facilitating natural product discovery research in the future.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00581?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00581</a>.Methods and materials, including strains, plasmids, chemicals, strain manipulation, cultivation and fermentation conditions, isolation and characterization of natural products from activated biosynthetic pathways, bioactivity assay, genome sequencing, gene overexpression and gene deletions (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00581/suppl_file/cb0c00581_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Genome Mining Reveals Novel Biosynthetic Gene Clusters in Entomopathogenic Bacteria

Global Analysis of Biosynthetic Gene Clusters Reveals Conserved and Unique Natural Products in Entomopathogenic Nematode-Symbiotic Bacteria

Genome sequencing and mining expand the naturalproduct repertoire of Lysobacter

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Dual phenazine gene clusters enable diversification during biosynthesis

Activation of a silent phenazine biosynthetic gene cluster reveals a novel natural product and a new resistance mechanism against phenazines

Discovery of Recombinases Enables Genome Mining of Cryptic Biosynthetic Gene Clusters in Burkholderiales Species.

Biosynthesis Of The Pyrrolidine Protein Synthesis Inhibitor Anisomycin Involves Novel Gene Ensemble And Cryptic Biosynthetic Steps

Discovery and Biosynthesis of Bosamycins from Streptomyces Sp. 120454.

Discovery of megapolipeptins by genome mining of a Burkholderiales bacteria collection

Elucidation of chalkophomycin biosynthesis reveals -hydroxypyrrole-forming enzymes

Characterization of the Azinomycin B Biosynthetic Gene Cluster Revealing a Different Iterative Type I Polyketide Synthase for Naphthoate Biosynthesis

A Versatile Transcription–Translation in One Approach for Activation of Cryptic Biosynthetic Gene Clusters

Phylogenomic analysis uncovers an unexpected capacity for the biosynthesis of secondary metabolites in Pseudoalteromonas

Genome Mining for Diazo-Synthesis-Related Genes in Streptomyces sp. CS057 Unveiled the Cryptic Biosynthetic Gene Cluster crx for the Novel 3,4-AHBA-Derived Compound Crexazone 2

Burkholderia genome mining for nonribosomal peptide synthetases reveals a great potential for novel siderophores and lipopeptides synthesis

Discovery of the leinamycin family of natural products by mining actinobacterial genomes

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

A Natural Product Chemist's Guide to Unlocking Silent Biosynthetic Gene Clusters